The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHeiq Regulatory News (HEIQ)

Share Price Information for Heiq (HEIQ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.20
Bid: 8.90
Ask: 9.20
Change: -0.23 (-2.48%)
Spread: 0.30 (3.371%)
Open: 9.00
High: 9.20
Low: 9.00
Prev. Close: 9.28
HEIQ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MAS Holdings invests in HeiQ AeoniQ

6 Jul 2023 07:00

RNS Number : 1142F
HeiQ PLC
06 July 2023
 

RNS Reach

06 July 2023

 

HeiQ Plc

("HeiQ" or "the Company")

 

MAS Holdings invests in HeiQ AeoniQ

 

HeiQ Plc (LSE: HEIQ), a leading company in materials innovation, announces that MAS Holdings ("MAS"), a global apparel & textile manufacturing and tech conglomerate headquartered in Sri Lanka, and the largest apparel and textile manufacturer in South Asia with approximately USD2 billion in turnover, through MAS' affiliate company, MAS Regent Pte Ltd., has secured a stake in HeiQ AeoniQ GmbH, a subsidiary of HeiQ Group that will produce HeiQ AeoniQ™, the Company's climate-positive cellulosic yarn.

With this US$2.5 million investment (US$1.5 million with the contract signature, and US$1 million upon reaching a mutually agreed milestone), MAS becomes the first manufacturer to partner with HeiQ AeoniQ™ in their efforts to provide a sustainable alternative to polyester and nylon. The investment by MAS is part of its strategy to drive a positive environmental impact. The MAS "Plan for Change" initiative aims to generate 50% of the company's revenue through sustainable products by 2025, revolutionizing the textile industry with a focus on innovation, sustainable sourcing, and pioneering circularity at scale.

HeiQ and MAS firmly believe that rapid scaling is key to facilitating the fast adoption of sustainable, circular technologies such as HeiQ AeoniQ™. Therefore, and subject to the completion of certain milestones and a mutual plan for commercialization, HeiQ and MAS have agreed to a five-year non-binding offtake agreement, pursuant to which the Company expects to receive purchase orders of up to US$100 million over a 5-year period, corresponding to 3,000 tons of HeiQ AeoniQ™ yarn in 2025 and 5,000 tons per year from 2026 to 2029.

Since its launch in Q4 2021 the HeiQ AeoniQ™ technology has been attracting the attention of major global players in the textile and clothing industries.

Using a proprietary manufacturing method, for the first time in history, a cellulosic filament yarn can be made from a wide range of non-valorized feedstock and is able to reproduce comparable performance features of polyester or nylon, while being sustainable and endlessly circular.

The HeiQ AeoniQ™ pilot plant in Austria has been manufacturing this continuous cellulosic filament yarn since Q3 2022, with an annual capacity of up to 100 tons that will be upscaled up to 300 tons per year by the end of 2023.

The scale-up of HeiQ AeoniQ™ production capacity will be driven over the coming years, and it is expected that by early 2026, the first large scale production site with an annual capacity of about 30,000 tons will be commissioned.

Carlo Centonze, CEO of HeiQ Group, said, "Since the beginning, HeiQ has pioneered textile innovation, revolutionizing sustainable functionality and enhancing the lives of billions. With the introduction of HeiQ AeoniQ™, we solidify our unwavering commitment to disrupting the textile industry -a sector that has long held the dubious distinction of being the world's second-largest polluter. MAS' investment and offtake agreement serves as a resounding endorsement of HeiQ AeoniQ™, and is a natural result of the trust built over a decade that HeiQ and MAS have been doing business together."

Group Chief Executive Officer of MAS Holdings, Suren Fernando adds, "MAS was built on the foundational belief of doing the right thing. As a global organization nurturing over 100,000 individuals, we are convinced of our responsibility to drive positive change within the apparel industry through sustainable product solutions. We believe that this investment is an important step in our efforts to reshape our industry by driving innovation, collaboration, and scale. With HeiQ AeoniQ™ as a key catalyst, we are poised to pave the way for a more sustainable future."

Polyester and nylon, two oil-based fibers, virtually non-recyclable, account for about 70% of all the global textile production, they take between 350 to 1000 years to degrade in nature, are currently close loop recycled at less than 1%, and are at the origin of 35% of the microplastics that can be found in today's oceans. HeiQ AeoniQ™ was innovated and is being hyper-scaled up to change this course of action.

 

For further information, please contact:

HeiQ Plc

Carlo Centonze (CEO)

+41 56 250 68 50

Cenkos Securities plc (Broker)

Stephen Keys / Callum Davidson

+44 (0) 207 397 8900

SEC Newgate (Media Enquiries)

Elisabeth Cowell / Molly Gretton / Tom Carnegie

+44 (0) 20 3757 6882

HeiQ@secnewgate.co.uk

 

About HeiQ

HeiQ is a Swiss-based international company that innovates pioneering and differentiating materials in partnership with established global brands. We bridge the academic and commercial worlds to conceive performance-enhancing materials and technologies, working with aligned brands to research, manufacture and bring products to market, aiming for lab to consumer in months. Our goal is to improve the lives of billions by innovating the materials that go into everyday products, making them more hygienic, comfortable, protective, and sustainable.

Our strong IP portfolio positions us as an innovation leader for niche, premium and high-margin products in the textile chemicals, man-made fibers, paints and coatings, antimicrobial plastics, probiotics and household cleaner markets. We have also expanded into healthcare facilities, probiotic cleaning, and hygiene coatings markets to help make hospitals and healthcare environments more hygienic.

We have developed over 200 technologies in partnership with 300 major brands. With a substantial research and development pipeline, including key technology development projects HeiQ AeoniQ, HeiQ ECOS, HeiQ GrapheneX, and HeiQ Synbio, HeiQ aims to deliver shareholder value through sales growth and entry into new lucrative markets through disruptive innovation and M&A.

We have built a strong reputation for ESG & sustainable innovation, having won multiple awards including the Swiss Technology Award twice and the Swiss Environmental Award. Under experienced leadership, we are committed to driving our profit in close connection with people and the planet. For more information, please visit www.heiq.com.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRASSEFWIEDSEIW
12
Date   Source Headline
22nd Apr 20247:00 amRNSHeiQ Synbio Secures Ecolab Contract Win
16th Apr 20242:17 pmRNSHolding(s) in Company
28th Mar 20247:00 amRNSUnaudited Interim Results
18th Mar 202412:41 pmRNSHolding(s) in Company
15th Mar 20247:00 amRNSHolding(s) in Company
14th Mar 20241:23 pmRNSCompletion of Fundraising, PDMR & Audit Update
13th Mar 20242:26 pmRNSResult of General Meeting
12th Mar 20247:00 amRNSBoard Changes
23rd Feb 20247:00 amRNSResult of Retail Offer
16th Feb 20247:00 amRNSResult of Placing
15th Feb 20245:49 pmRNSRetail Offer
15th Feb 20245:46 pmRNSAcquisition, Fundraising, Trading Update & GM
6th Dec 20232:46 pmRNSAgreed Changes to Concert Party
4th Dec 20237:00 amRNSDirector/PDMR Dealing
1st Dec 20233:04 pmRNSResult of General Meeting
30th Nov 20237:06 amRNSStatement Confirming Settlement
27th Nov 20237:00 amRNSBoard Appointment
8th Nov 20237:00 amRNSNotice of General Meeting
3rd Nov 20239:14 amRNSHolding(s) in Company
3rd Nov 20237:05 amRNSHolding(s) in Company
31st Oct 20237:43 amRNSFiling of Annual Report & Restoration of Trading
31st Oct 20237:30 amRNSRestoration - HEIQ PLC
30th Oct 20237:01 amRNSInterim Results
30th Oct 20237:00 amRNSResults for year ended 31 December 2022
23rd Oct 20237:00 amRNSNotice of Results and Audit Update
29th Sep 20237:00 amRNSAccounts Update
6th Jul 20237:00 amRNSMAS Holdings invests in HeiQ AeoniQ
29th Jun 20232:16 pmRNSResult of AGM
29th Jun 20237:00 amRNSAGM Statement
6th Jun 20237:00 amRNSNotice of AGM
2nd May 20237:44 amRNSTemporary Suspension of Trading in Ordinary Shares
27th Apr 20233:55 pmRNSTemporary Suspension
13th Jan 20232:09 pmRNSUpdate re. admission of Consideration Shares
12th Jan 20237:00 amRNSCompletion of Acquisition
10th Jan 20237:00 amRNSDirector / PDMR Dealing
6th Jan 20237:00 amRNSDirector / PDMR Dealing
5th Jan 20237:03 amRNSDirector/PDMR Shareholding
4th Jan 20237:00 amRNSTrading Update and Acquisition
14th Dec 20227:00 amRNSIncreased interest in HeiQ Chrisal to 71%
2nd Dec 20227:00 amRNSAcquisition of Chem-Tex Laboratories, Inc
7th Nov 20227:00 amRNSChange of Auditor
10th Oct 20227:00 amRNSFiles Breach of Exclusive Agreement Complaint
13th Sep 20227:00 amRNSInterim Results
30th Aug 20227:00 amRNSNotice of H1 2022 Results and Presentation
8th Aug 202210:33 amRNSIssue of Equity and Total Voting Rights
29th Jun 202211:06 amRNSResult of AGM
14th Jun 20227:00 amRNSCommercial progress of HeiQ’s Hygiene technologies
18th May 20227:00 amRNSNotice of AGM
12th May 20227:00 amRNSPayment of Earnout Consideration
28th Apr 20227:00 amRNSResults for the year ended 31 December 2021
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.